ArticleRheumatology and therapy2024

Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.

Qinyi Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.